Dietary Supplements and Diets Show No Impact on Cardiovascular Risk

Americans spend billions in dietary supplements every year but, in truth, this money is only wasted, according to evidence form a recent study published in Intern Med.

Nuevas alternativas prometedoras para la insuficiencia mitral

Most of dietary interventions and nutritional supplements including multi-vitamins, selenium and antioxidants, do not reduce cardiovascular risk or mortality, according to this large analysis and systematic revision of several randomized studies.

Modest benefits were indeed observed when reducing salt consumption and when incorporating omega 3 polyunsaturated fatty acids and folic acid.

On the other hand, combining calcium and vitamin D seems to increase stroke risk.

However, despite different guidelines and societies claim the evidence behind these recommendations is insufficient, one every other American consume some sort of vitamin or dietary supplement, and the proportion increases with age.


Read also: Supervised Exercise and Revascularization for Intermittent Claudication.


In this context, researchers wanted to provide quality evidence by testing the effect of nutritional supplements and, to this end, included 9 systematic reviews and 4 randomized studies with nearly one million participants. Data included studies VITAL and ASCEND, which studied the impact of vitamin D and omega-3.

Globally, they were able to find certain evidence that reduced salt consumption has a modest positive effect on global mortality in persons with normal blood pressure (RR 0.90; 95% CI 0.85-0.95) and a more significant positive effect on cardiovascular mortality in hypertensives (RR 0.67; 95% CI 0.46-0.99).

Additionally, “low certainty” evidence suggested omega-3 acids reduce the risk of infarction and heart disease.

There was also “low certainty” evidence that folic acid reduced stroke risk, though this benefit was driven basically by one single study conducted in China.


Read also: Many Guidelines, Much Confusion. Blood Pressure Targets in the Elderly.


Finally, and with “moderate certainty”, calcium and vitamin D supplements would increase stroke risk (RR 1.17; 95% CI 1.05-1.30).

No other supplement, including vitamins A, B complex, C, D or E, antioxidants, iron or other dietary interventions (including reduced fat intake) impact mortality or cardiovascular events, neither positively nor negatively.

Most people are wasting their money in vitamins, buying supplements at the pharmacy, when it would be more sensible, rational and a lot cheaper to buy vitamins at the groceries’.

Most surprisingly, the “Mediterranean diet” showed no impact, seeing as the PREDIMED outcomes suggest the benefit of diets rich in vegetables, whole grains, nuts and olive oil. Researchers speculate these results might have been counterbalanced with other study results with null outcomes.

Original title: Effects of nutritional supplements and dietary interventions on cardiovascular outcomes: an umbrella review and evidence map.

Reference: Khan SU et al. Ann Intern Med. 2019;171:190-198.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes

Various studies and registries have previously shown the impact of post-percutaneous coronary intervention (PCI) complications on the survival of patients with ST-segment elevation acute...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

Several in vivo studies have shown that ultrathin stents present lower thrombogenic risk vs. thin-strut stents, which reflects in lower rates of target lesion...

Should We Withdraw Anticoagulation Before TAVR?

Approximately one-third of patients undergoing transcatheter aortic valve replacement (TAVR) have atrial fibrillation and are on oral anticoagulant (OAC) therapy. This creates a complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...